Diagnostic and Interventional Cardiology

3DR Labs, an Accumen company, today announced the launch of its Cardiac Center of Excellence and Imaging Excellence Advisory Services to support radiology departments in hospital and outpatient settings nationwide

News | AHRA

3DR Labs Introduces New Imaging Services to Meet Specific Radiology Market Needs

July 18, 2022 — 3DR Labs, an Accumen company, today announced the launch of its Cardiac Center of Excellence and Imaging ...

July 19, 2022

Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced the CE Mark submission for its MAGiC catheter.

News | Catheter

Stereotaxis Announces CE Mark Submission for Robotically Navigated Magic Ablation Catheter

July 18, 2022 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...

July 19, 2022

News | Cardiovascular Clinical Studies

scPharmaceuticals Inc. Announces Positive Results from the AT HOME-HF Phase 2 Pilot Study in Heart Failure

July 18, 2022 — scPharmaceuticals Inc., a pharmaceutical company focused on developing and commercializing products that ...

July 19, 2022

Sponsored Content

Feature | Nuclear Imaging

Cardiac PET/CT — A New Standard for Cardiac Imaging

Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...

November 12, 2025

News | SCCT

SCCT2022 Presents Distinguished Awards

During the Society of Cardiovascular Computed Tomography 17th Annual Scientific Meeting (SCCT2022), three awards were ...

July 18, 2022

The ACC has named Melvin R. Echols, MD, FACC, as its new Chief Diversity, Equity and Inclusion Officer

News | ACC

ACC Names Dr. Melvin Echols as Chief Diversity, Equity and Inclusion Officer

July 15, 2022 — The ACC has named Melvin R. Echols, MD, FACC, as its new Chief Diversity, Equity and Inclusion Officer ...

July 15, 2022

MMRI Scientist Dr. Nathan Tucker co-authors groundbreaking study with team from The Broad Institute of MIT and Harvard, Bayer AG

News | Cardiovascular Clinical Studies

Molecular Heart Mapping and Cripsr Technology Create New Possibilities for Health Science

July 15, 2022 — Imagine, if scientists had a map of the heart, so granular in its accuracy that it even profiled details ...

July 15, 2022

Sponsored Content

Feature

Intuitive Imaging Workflow System Offers Improved Efficiency, Flexibility

SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...

June 17, 2025

The American Heart Association, the leading voluntary organization devoted to longer, healthier lives, recognizes structural racism as a major cause of poor health and premature death from heart disease and stroke

News | Heart Failure

Winning Scientific Research Announced for Heart Failure and Social/Structural Determinants of Health

July 15, 2022 — The American Heart Association, the leading voluntary organization devoted to longer, healthier lives ...

July 15, 2022

This model heart ventricle, made with real living heart cells, beats strongly enough to pump fluid inside a tube. It can be used to study heart disease and test out potential therapies, without the need for invasive surgery.

News | Artificial Heart

Reverse Engineering the Heart: University of Toronto Engineering Team Creates Bioartificial Left Ventricle

July 14, 2022 — University of Toronto Engineering researchers have grown a small-scale model of a human left heart ...

July 14, 2022

More than one in four pregnancy-related deaths (26.5%) in the U.S. are tied to poor heart health, especially among people of color, putting both parents-to-be and their babies at risk, according to the American Heart Association Heart Disease and Stroke Statistics 2022 Update.

News | Womens Cardiovascular Health

$20 Million Awarded for Research to Improve Outcomes in Pregnancy, Infant CVD Health

July 14, 2022 — More than one in four pregnancy-related deaths (26.5%) in the U.S. are tied to poor heart health ...

July 14, 2022

Sponsored Content

ASCEND provides the tools that not only address the unique needs of each cardiovascular subspecialty and to care for patients from infancy into their golden years, they also innovates next-generation solutions and services that empower the provider community to truly transform their cardiovascular services

Feature | Information Technology

SPONSORED CONTENT: Unveiling the Future of Cardiovascular Workflow

Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...

March 21, 2024

Anumana, Inc., an AI-driven health technology company and portfolio company of nference, has launched a multi-year strategic collaboration with Novartis Pharmaceuticals Corporation (“Novartis”) to deploy a series of artificial intelligence (AI)-powered software solutions that will detect hidden cardiovascular conditions

News | Artificial Intelligence

Anumana Collaborates with Leading Global Health Care Company to Detect Heart Disease Using Artificial Intelligence

July 14, 2022 — Anumana, Inc., an AI-driven health technology company and portfolio company of nference, has launched a ...

July 14, 2022

News | Cardiac Imaging

AvoMD Partners with the SCCT to bring guidelines to the point-of-care

July 14, 2022 – AvoMD, a next-generation application-based clinical decision support platform, is working with the ...

July 14, 2022

The authors analyzed data about 8,224 children who received cardiac transplants from January 1994 through September 2019. The data came from the Scientific Registry of Transplant Recipients (SRTR), a national database of all organ transplants in the United States. The researchers adjusted their analyses for factors including age, sex, cognitive difficulties, insurance status, transplant year and the reason for heart transplant.

News | Pediatric Cardiology

Study Finds Risk Disparity for Black Children Who Have Stroke After Heart Transplant

July 13, 2022 — Black children who underwent heart transplant surgery for the first time were more than three times as ...

July 13, 2022

Sponsored Content

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision

Feature | Cardiac Imaging

SPONSORED CONTENT: Finding the Right Solution

Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...

March 05, 2024

Adults with abnormal heart metabolism are up to three times more likely to experience life-threatening arrhythmias (an irregular heart rhythm), and MRI techniques could be used to detect the condition and predict future sudden cardiac death (SCD),

News | Sudden Cardiac Arrest

Johns Hopkins Medicine Study: Abnormal Heart Metabolism May Predict Future Sudden Cardiac Death

July 13, 2022 — Adults with abnormal heart metabolism are up to three times more likely to experience life-threatening ...

July 13, 2022

the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation to the AccuCinch Ventricular Restoration System

News | Heart Failure

Ancora Heart Receives Breakthrough Device Designation from FDA for the AccuCinch Ventricular Restoration System

July 13, 2022 — Ancora Heart, Inc., a company developing a novel device-based therapy to address heart failure, today ...

July 13, 2022

July/August 2022 issue of Diagnostic and Interventional Cardiology

Feature | Cardiovascular Business

DAIC's July/August Digital Edition is Now Available

View the July/August digital edition of Diagnostic and Interventional Cardiology (DAIC), including links to videos ...

July 13, 2022